US Stock MarketDetailed Quotes

PCSA Processa Pharmaceuticals

Watchlist
  • 1.4800
  • -0.1000-6.33%
Close May 31 16:00 ET
  • 1.4900
  • +0.0100+0.68%
Post 19:02 ET
4.23MMarket Cap-244P/E (TTM)

Processa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.08%-2.05M
16.05%-8.06M
14.96%-2.12M
40.80%-1.76M
11.42%-2.06M
-17.26%-2.11M
-10.18%-9.61M
8.42%-2.5M
-91.54%-2.97M
-6.22%-2.33M
Net income from continuing operations
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-139.98%-27.42M
-308.70%-13.01M
-101.54%-6.02M
-63.58%-5.16M
Depreciation and amortization
--139
-99.97%222
-99.93%140
-99.96%82
--0
--0
-0.31%788.5K
0.00%197.12K
0.73%197.12K
-0.86%197.12K
Other non cash items
-98.39%21.37K
256.91%1.39M
-63.13%20.98K
-64.74%20.57K
-91.90%20.18K
5,083.37%1.33M
1.50%390.13K
161.54%56.89K
173.85%58.34K
-22.33%249.23K
Change In working capital
107.08%488.34K
11.33%605.21K
-98.55%3.13K
137.21%157.47K
-44.78%208.79K
-36.69%235.82K
146.12%543.6K
130.86%216.15K
-287.59%-423.18K
412.48%378.13K
-Change in receivables
----
--0
--0
--0
----
----
941.10%70.27K
--0
--0
--0
-Change in prepaid assets
-83.07%68.67K
354.45%956.83K
236.11%120.49K
541.50%173.36K
365.13%257.37K
87.16%405.62K
120.68%210.55K
74.97%-88.53K
-87.28%27.02K
117.30%55.33K
-Change in payables and accrued expense
407.06%463.1K
-177.38%-272.72K
-128.05%-90.64K
99.54%-1.99K
-108.44%-29.27K
-236.50%-150.81K
311.25%352.44K
199.28%323.14K
-1,017.58%-428.04K
40.96%346.86K
-Change in other current liabilities
-11.40%-21.08K
10.28%-78.9K
-13.23%-20.97K
11.14%-19.7K
19.76%-19.31K
18.40%-18.93K
-0.85%-87.94K
19.77%-18.52K
-1.67%-22.16K
-12.59%-24.06K
-Change in other working capital
-43,692.16%-22.33K
99.30%-12
-11,378.43%-5.75K
--5.79K
--0
97.12%-51
-101.99%-1.72K
-97.12%51
--0
--0
Cash from discontinued investing activities
Operating cash flow
3.08%-2.05M
16.05%-8.06M
14.96%-2.12M
40.80%-1.76M
11.42%-2.06M
-17.26%-2.11M
-10.18%-9.61M
8.42%-2.5M
-91.54%-2.97M
-6.22%-2.33M
Investing cash flow
Cash flow from continuing investing activities
-2.78K
0
0
0
Net PPE purchase and sale
----
---2.78K
--0
----
----
----
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
----
---2.78K
--0
----
----
----
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
-1.40%6.26M
1,712.15%6.27M
42.89%-30.61K
-49.65%-52.75K
0
2,217.36%6.35M
-103.97%-388.84K
-140.80%-53.6K
80.97%-35.25K
0
Net issuance payments of debt
---895
----
----
----
----
--0
----
----
----
----
Net common stock issuance
-1.25%6.27M
1,725.71%6.32M
42.89%-30.61K
--0
--0
2,217.36%6.35M
-103.89%-388.84K
-138.96%-53.6K
-25.97%-35.25K
--0
Net other financing activities
---8.56K
---52.75K
--0
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-1.40%6.26M
1,712.15%6.27M
42.89%-30.61K
-49.65%-52.75K
--0
2,217.36%6.35M
-103.97%-388.84K
-140.80%-53.6K
80.97%-35.25K
--0
Net cash flow
Beginning cash position
-27.64%4.71M
-60.58%6.5M
-24.23%6.86M
-28.08%8.68M
-25.38%10.74M
-60.58%6.5M
7.01%16.5M
-52.58%9.05M
-42.09%12.06M
-37.55%14.39M
Current changes in cash
-0.56%4.21M
82.02%-1.8M
15.54%-2.15M
39.64%-1.82M
11.42%-2.06M
301.53%4.24M
-1,024.21%-9.99M
1.72%-2.55M
-73.16%-3.01M
-5.12%-2.33M
End cash Position
-16.96%8.92M
-27.64%4.71M
-27.64%4.71M
-24.23%6.86M
-28.08%8.68M
-25.38%10.74M
-60.58%6.5M
-60.58%6.5M
-52.58%9.05M
-42.09%12.06M
Free cash flow
3.08%-2.05M
16.02%-8.07M
14.96%-2.12M
40.70%-1.76M
11.42%-2.06M
-17.26%-2.11M
-10.18%-9.61M
8.42%-2.5M
-91.54%-2.97M
-6.22%-2.33M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.08%-2.05M16.05%-8.06M14.96%-2.12M40.80%-1.76M11.42%-2.06M-17.26%-2.11M-10.18%-9.61M8.42%-2.5M-91.54%-2.97M-6.22%-2.33M
Net income from continuing operations 32.21%-2.73M59.45%-11.12M81.52%-2.4M65.42%-2.08M49.41%-2.61M-24.63%-4.02M-139.98%-27.42M-308.70%-13.01M-101.54%-6.02M-63.58%-5.16M
Depreciation and amortization --139-99.97%222-99.93%140-99.96%82--0--0-0.31%788.5K0.00%197.12K0.73%197.12K-0.86%197.12K
Other non cash items -98.39%21.37K256.91%1.39M-63.13%20.98K-64.74%20.57K-91.90%20.18K5,083.37%1.33M1.50%390.13K161.54%56.89K173.85%58.34K-22.33%249.23K
Change In working capital 107.08%488.34K11.33%605.21K-98.55%3.13K137.21%157.47K-44.78%208.79K-36.69%235.82K146.12%543.6K130.86%216.15K-287.59%-423.18K412.48%378.13K
-Change in receivables ------0--0--0--------941.10%70.27K--0--0--0
-Change in prepaid assets -83.07%68.67K354.45%956.83K236.11%120.49K541.50%173.36K365.13%257.37K87.16%405.62K120.68%210.55K74.97%-88.53K-87.28%27.02K117.30%55.33K
-Change in payables and accrued expense 407.06%463.1K-177.38%-272.72K-128.05%-90.64K99.54%-1.99K-108.44%-29.27K-236.50%-150.81K311.25%352.44K199.28%323.14K-1,017.58%-428.04K40.96%346.86K
-Change in other current liabilities -11.40%-21.08K10.28%-78.9K-13.23%-20.97K11.14%-19.7K19.76%-19.31K18.40%-18.93K-0.85%-87.94K19.77%-18.52K-1.67%-22.16K-12.59%-24.06K
-Change in other working capital -43,692.16%-22.33K99.30%-12-11,378.43%-5.75K--5.79K--097.12%-51-101.99%-1.72K-97.12%51--0--0
Cash from discontinued investing activities
Operating cash flow 3.08%-2.05M16.05%-8.06M14.96%-2.12M40.80%-1.76M11.42%-2.06M-17.26%-2.11M-10.18%-9.61M8.42%-2.5M-91.54%-2.97M-6.22%-2.33M
Investing cash flow
Cash flow from continuing investing activities -2.78K000
Net PPE purchase and sale -------2.78K--0--------------0--0--------
Cash from discontinued investing activities
Investing cash flow -------2.78K--0--------------0--0--------
Financing cash flow
Cash flow from continuing financing activities -1.40%6.26M1,712.15%6.27M42.89%-30.61K-49.65%-52.75K02,217.36%6.35M-103.97%-388.84K-140.80%-53.6K80.97%-35.25K0
Net issuance payments of debt ---895------------------0----------------
Net common stock issuance -1.25%6.27M1,725.71%6.32M42.89%-30.61K--0--02,217.36%6.35M-103.89%-388.84K-138.96%-53.6K-25.97%-35.25K--0
Net other financing activities ---8.56K---52.75K--0----------------------------
Cash from discontinued financing activities
Financing cash flow -1.40%6.26M1,712.15%6.27M42.89%-30.61K-49.65%-52.75K--02,217.36%6.35M-103.97%-388.84K-140.80%-53.6K80.97%-35.25K--0
Net cash flow
Beginning cash position -27.64%4.71M-60.58%6.5M-24.23%6.86M-28.08%8.68M-25.38%10.74M-60.58%6.5M7.01%16.5M-52.58%9.05M-42.09%12.06M-37.55%14.39M
Current changes in cash -0.56%4.21M82.02%-1.8M15.54%-2.15M39.64%-1.82M11.42%-2.06M301.53%4.24M-1,024.21%-9.99M1.72%-2.55M-73.16%-3.01M-5.12%-2.33M
End cash Position -16.96%8.92M-27.64%4.71M-27.64%4.71M-24.23%6.86M-28.08%8.68M-25.38%10.74M-60.58%6.5M-60.58%6.5M-52.58%9.05M-42.09%12.06M
Free cash flow 3.08%-2.05M16.02%-8.07M14.96%-2.12M40.70%-1.76M11.42%-2.06M-17.26%-2.11M-10.18%-9.61M8.42%-2.5M-91.54%-2.97M-6.22%-2.33M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg